| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |